Vanguard Morningstar Value ETF

Recent news

• LifeSci Capital Maintains VTv Therapeutics(VTVT.US) With Buy Rating, Maintains Target Price $60
  Market Newswire · 2026/10/6
• Rating change
  BTIG Maintains VTv Therapeutics(VTVT.US) With Buy Rating, Raises Target Price to $57
  Market Newswire · 2026/7/16
• Rating change
  A Quick Look at Today's Ratings for VTv Therapeutics(VTVT.US), With a Forecast Between $45 to $58
  Market Newswire · 2026/5/14
• Rating change
  H.C. Wainwright Maintains VTv Therapeutics(VTVT.US) With Buy Rating, Maintains Target Price $45
  Market Newswire · 2026/5/27
• Rating change
  A. G. P. Maintains VTv Therapeutics(VTVT.US) With Buy Rating, Maintains Target Price $55
  Market Newswire · 2026/5/14
• Rating change
  Rodman & Renshaw Initiates VTv Therapeutics(VTVT.US) With Buy Rating, Announces Target Price $67
  Market Newswire · 2026/6/30
• Company notice
  4: vTv Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director BAKER BROS. ADVISORS LP
  SEC · 2026/6/30
• H.C. Wainwright Maintains VTv Therapeutics(VTVT.US) With Buy Rating, Maintains Target Price $42
  Market Newswire · 2026/9/22
• BTIG Maintains VTv Therapeutics(VTVT.US) With Buy Rating, Maintains Target Price $57
  Market Newswire · 2026/10/15
• Company notice
  vTv Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Phillips Anne M.
  SEC · 2025/6/13
• Rating change
  TD Cowen Maintains VTv Therapeutics(VTVT.US) With Buy Rating, Maintains Target Price $67
  Market Newswire · 2026/5/15
• Rating change
  H.C. Wainwright Maintains VTv Therapeutics(VTVT.US) With Buy Rating, Cuts Target Price to $42
  Market Newswire · 2026/8/7
• Company notice
  4: vTv Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Phillips Anne M.
  SEC · 2026/6/30
• LifeSci Capital Initiates VTv Therapeutics(VTVT.US) With Buy Rating, Announces Target Price $60
  Market Newswire · 2026/9/2
• Rating change
  H.C. Wainwright Sticks to Their Buy Rating for VTv Therapeutics (VTVT)
  TipRanks · 2026/5/27
• Company notice
  vTv Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director BAKER BROS. ADVISORS LP
  SEC · 2025/9/6
• Company notice
  vTv Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director BAKER BROS. ADVISORS LP
  SEC · 2025/6/13
• Rating change
  Evercore Initiates VTv Therapeutics(VTVT.US) With Buy Rating, Announces Target Price $44
  Market Newswire · 2026/3/13
• Roth MKM Maintains VTv Therapeutics(VTVT.US) With Buy Rating, Maintains Target Price $58
  Market Newswire · 2026/10/6
• Rating change
  Analysts Offer Insights on NA Companies: VTv Therapeutics (VTVT), TripAdvisor (TRIP) and Caris Life Sciences, Inc. (CAI)
  TipRanks · 2026/8/7
• H.C. Wainwright Sticks to Its Buy Rating for VTv Therapeutics (VTVT)
  TipRanks · 2026/9/22
• Rating change
  BTIG Maintains VTv Therapeutics(VTVT.US) With Buy Rating, Maintains Target Price $57
  Market Newswire · 2026/8/7
• Roth MKM Maintains VTv Therapeutics(VTVT.US) With Buy Rating, Maintains Target Price $58
  Market Newswire · 2026/8/7

Headlines are aggregated automatically and are not independently verified or edited by our team.